Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cannabis Club Systems Reaches 900-Club Milestone as AI Integration Drives Global Expansion
-
New Benchmark from CCM Institute Warns 80% of Businesses Lack Clear Contract Accountability
-
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
-
Stan Taylor Launches The Black Book of Power, Calling for a Consciousness Shift as 60,000 Readers Embrace Counter-Manipulation Training
-
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 202
-
Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner
-
Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features
-
RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives
-
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
-
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Dis
-
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
-
Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates
-
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrol
-
Most Trusted Crypto Casinos USA: Jackbit Leads 2025 Crypto Gaming With Instant Withdrawals & No KYC Access
-
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
-
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
-
BexBack Unlocks No-KYC 100x Leverage With New $100 Bonus for Beginners
-
Dancetime Launches Guide to Top 8 Outdoor Party Hire Essentials Amid Surge in Sydney Events
-
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
-
CentFX named Best B2B Liquidity Provider At Forex Expo Dubai 2025
-
How modeling scenarios informed the emergence of a global carbon market coalition at COP30
-
Ecorobotix Showcases World-First AI Capability for Safe, Targeted Use of Non-Selective Contact Herbicides at Agritechnica
-
Zastre & Co Opens Vancouver Office, Expanding Elite Boutique Advisory Platform Across North America
-
Zastre & Co Opens Vancouver Office, Expanding Elite Boutique Advisory Platform Across North America
-
DeFi Crypto Mutuum Finance (MUTM) Raises Over $18.6 Million as Phase 6 Approaches Full Allocation
-
Saudi “Emerge” Emergency and Crisis Resilience Platform Named Among the World’s Best Smart City Solutions in the 2025 Smart City Awards
-
How Moving Expert Mike Marschhausen of Portsmouth Explains Moving Estimates for HelloNation
-
How Towing Expert Michelle Sullivan of Fredericksburg, VA, Explains Understanding Towing Capacity for HelloNation
-
Real Estate Expert Denise Abmont of Eagle Shares Tips for Relocating to Another State in HelloNation
-
Fine Dining Expert Carolyn Weeks of Traverse City Shares Why Food Helps People Try New Spirits in HelloNation
-
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
-
Mutuum Finance (MUTM) Nears $20 Million Raised as Roadmap Phase 2 Progresses Toward V1 Launch
-
Fangzhou Awarded “Golden Bull Award” for Leadership in AI-Powered Chronic Disease Management
-
Norwegian Premium Nutrition Brand NYO3 Makes Its Seventh Appearance at CIIE
-
Fintradix Releases Quarterly Performance Report Highlighting Double-Digit Growth
-
Canacol Energy Ltd Provides Information on Arbitration Process
-
Ascot Announces Launch of C$0.01 Rights Offering
-
In Response to Rising Hate, Young Christian Leaders Mobilize Against Antisemitism
-
URBANICA Furniture Redefines Workspace Simplicity With Modular, Eco-Adaptive Designs
-
Smile Spa Camarillo Officially Opens its Doors, Offering State-of-the-Art Dental Care in Ventura County
-
South Star Announces Upsize of Non-Brokered Private Placement
-
CORRECTION – Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2025 Results
-
NEXTGEN DIGITAL CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT OF UNITS
-
Aeroméxico Announces Webcast of Third Quarter 2025 Financial Results
-
Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
-
Carpathian Capital Management Announces Record Investor Distribution
-
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease In October 2025 of 0.8% Compared to 2024
-
Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025
-
Beyond Meat® to Report Third Quarter 2025 Financial Results on November 10, 2025 and Hold Conference Call on November 11, 2025
-
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements a
